Stimulant use disorder diagnosis and opioid agonist treatment dispensation following release from prison: a cohort study

Original research
par
Palis, Heather et al

Date de publication

2022

Géographie

Canada

Langue de la ressource

English

Texte disponible en version intégrale

Oui

Open Access / OK to Reproduce

Oui

Évalué par des pairs

Yes

L’objectif

In the context of rising concurrent stimulant use among people with opioid use disorder, this study aims to investigate the impact of stimulant use disorder on opioid agonist treatment dispensation following release from prison in BC.

Constatations/points à retenir

People with mental illness and stimulant use disorder diagnoses have a lower odds of being dispensed agonist treatment post-release compared to people with mental illness alone. There is a critical need to scale up and adapt opioid agonist treatment and ancillary harm reduction, and treatment services to reach people released from prison who have concurrent stimulant use disorder and mental illness diagnoses.

La conception ou méthodologie de recherche

Linked health and corrections records (n=13,380)

Mots clés

About PWUD
Stimulants
Substitution/OAT
Legal system/law enforcement